Dublin, May 27, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Varicose Vein Treatment Market - Forecasts to 2021" report to their offering.
The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021.
Shift towards less-invasive treatment procedures, availability of advanced varicose vein treatment devices, and huge burden of varicose vein cases in North America and Europe is driving the growth of the market. Other growth factors include improving patient compliance & reliability, growing healthcare expenditure, and rapid growth in aging population.
However, dearth of training for vascular surgeons, high cost of varicose vein treatment procedures, and implementation of healthcare reforms in the U.S. are some of the key factors restraining the growth of this market. In addition to this, challenges associated with inconsistent reimbursement scenario for varicose vein treatment procedures and sustainability of players in the highly competitive market also limits the growth of the market.
In 2016, North America is expected to command the largest share of the market in North America and Europe. However, Europe is expected to register the highest growth rate during the forecast period from 2016 to 2021, due to increasing adoption of advanced treatment procedures and favorable government initiatives in this region.
Companies Mentioned:
- Angiodynamics, Inc.
- Biolitec Ag
- Lumenis Ltd.
- Medtronic, PLC
- Syneron Medical Ltd.
Key Topics Covered:
1. Introduction
2.Research Methodology
3. Executive Summary
4. Market Dynamics
5. Varicose Vein Treatment Market in North America and Europe, By Treatment Mode
6. Varicose Vein Treatment Market in North America and Europe, By Product
7. Varicose Vein Treatment Market, By Region
8. Competitive Landscape
9. Company Profiles
For more information visit http://www.researchandmarkets.com/research/vknr39/varicose_vein